title: Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF-κB dependent human transformed follicular lymphoma cell line.
authors.affiliation: Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. smithm14@ccf.org.
authors.forename: Mitchell R
authors.initials: MR
authors.lastname: Smith
authors.forename: Fang
authors.initials: F
authors.lastname: Jin
authors.forename: Indira
authors.initials: I
authors.lastname: Joshi
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D008224:Lymphoma, Follicular / Q000378:metabolism*; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D016328:NF-kappa B; C540932:milatuzumab; C493846:veltuzumab
keywords: JNK; NF-κB; antibody-induced apoptosis; follicular lymphoma